Effect of Icogenin on and its mechanism in anti-metastasis of pancreatic cancer BxPC3 cells

Yaoxue Xuebao

Volumn 44, Issue 5, 2009, Pages 456-461

  Su, Fu Qin ^a,b   Li, Hong Yan ^a   Zhang, Yi ^a   Hou, Shu Jie ^a   Lei, Ping Sheng ^a   Chen, Xiao Guang ^a  

^a INSTITUTE OF MATERIA MEDICA   (China)

^b QIQIHAR MEDICAL UNIVERSITY   (China)

Author keywords

Icogenin; Metastasis; Pancreatic cancer cell

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; GELATINASE A; ICOGENIN; MITOGEN ACTIVATED PROTEIN KINASE; SAPONIN DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CELL ADHESION; CELL MOTILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME RELEASE; HUMAN; HUMAN CELL; IN VITRO STUDY; METASTASIS INHIBITION; PANCREAS CANCER; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; WOUND HEALING; ZYMOGRAPHY;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; DOSE-RESPONSE RELATIONSHIP, DRUG; DRACAENA; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; MATRIX METALLOPROTEINASE 2; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; NEOPLASM INVASIVENESS; PANCREATIC NEOPLASMS; PHOSPHORYLATION; SAPONINS; SIGNAL TRANSDUCTION; STEROIDS;

EID: 67650932861     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Hou S, Xu P, Zhou L, et al. Synthesis and antitumor activity of icogenin and its analogue [J]. Bioorg Med Chem Lett, 2006, 16: 2454-2458.
2. Hernandez JC, Leon F, Quintana J, et al. Icogenin, a new cytotoxic steroidal saponin isolated from Dracaena draco [J]. Bioorg Med Chem, 2004, 12: 4423-4429.
3. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002 [J]. CA Cancer J Clin, 2005, 55:74-108.
4. Burris HA 3rd, Moore MJ, Andersen J, et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial [J]. J Clin Oncol, 1997, 15: 2403-2413.
5. Van Laar ES, Roth S, Weitman S, et al. Activity of irofulven against human pancreatic carcinoma cell lines in vitro and in vivo [J]. Anticancer Res, 2004, 24: 59-65.
6. Song IH. Cancer metastasis and metastasis suppressors [J]. Korean J Gastroenterol, 2004, 43: 1-7.
7. Li J, Zhu J, Melvin WS, et al. A structurally optimized celecoxib derivative inhibits human pancreatic cancer cell growth [J]. J Gastrointest Surg, 2006, 10: 207-214.
8. Sun Y, Liu M, Yang B, et al. Role of siRNA silencing of MMP-2 gene on invasion and growth of laryngeal squamous cell carcinoma [J]. Eur Arch Otorhinolaryngol, 2008, 265: 1385-1391.
9. Liu J, Lin A. Wiring the cell signaling circuitry by the NF-kappa B and JNK1 crosstalk and its applications in human diseases [J]. Oncogene, 2007, 26: 3267-3278.
10. Zhuang ZH, Zhou Y, Yu MC, et al. Regulation of drosophila p38 activation by specific MAP2 kinase and MAP3 kinase in response to different stimuli [J]. Cell Signal, 2006, 18: 441-448.
11. Cheng YJ, Lee CH, Lin YP, et al. Caspase-3 enhances lung metastasis and cell migration in a protease-independent mechanism through the ERK pathway [J]. Int J Cancer, 2008, 123: 1278-1285.